Gelteq (GELS) Cash from Operations (2024)

Gelteq (GELS) recorded quarterly Cash from Operations of 2350754.9 in Q4 2024.

Gelteq (GELS) Cash from Operations (2024) Analysis & Trends

Gelteq's Cash from Operations history runs 1 years deep, the most recent figure standing at 2350754.9 for Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -40.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 401.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 463.30 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 145.80 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -165.74 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 89.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 125.13 Mn
10 Gelteq 10.57 Mn 10.34 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.35 Mn
Dec 31, 2024 -2.35 Mn